![Fernando Doñate](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Fernando Doñate worked as the Director of Preclinical Research at Proacta, Inc. from 2008 to 2010.
He also worked as the Associate Director of Biology at Attenuon, LLC.
Dr. Doñate earned a doctorate degree from the University of Missouri in 1994 and an undergraduate degree from Universidad Complutense de Madrid in 1988.
Former positions of Fernando Doñate
| Companies | Position | End |
|---|---|---|
Attenuon, LLC
 Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Corporate Officer/Principal | - |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Chief Tech/Sci/R&D Officer | - |
Training of Fernando Doñate
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Health Technology |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Complutense de Madrid
 Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Fernando Doñate
